Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115 | 50 | 566 | 16 | 23 |
| Receivables | 1 | 1 | 1 | 1 | N/A |
| TOTAL | $227 | $187 | $1,276 | $1,074 | $1,685 |
| Non-Current Assets | |||||
| PPE Net | 7 | 7 | 396 | 394 | 248 |
| Other Non-Current Assets | 2 | 2 | 6 | 12 | 6 |
| TOTAL | $9 | $9 | $402 | $406 | $254 |
| Total Assets | $236 | $196 | $1,678 | $1,480 | $1,939 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,875 | 7,162 | 5,924 | 4,076 | 4,002 |
| Accrued Expenses | 3,070 | 2,925 | 2,489 | 2,203 | 1,340 |
| TOTAL | $17,595 | $18,237 | $16,422 | $13,780 | $10,554 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 857 | 696 | 687 | 0 | 0 |
| TOTAL | $857 | $696 | $687 | $N/A | $N/A |
| Total Liabilities | $18,452 | $18,933 | $17,109 | $13,780 | $10,554 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,629 | 2,817 | 2,817 | 2,817 | 2,656 |
| Common Shares | 57 | 45 | 1 | 42 | 42 |
| Retained earnings | -185,538 | -173,297 | -169,202 | -164,626 | -159,384 |
| Other shareholders' equity | -52 | -9 | -330 | -24 | 4 |
| TOTAL | $-18,216 | $-18,737 | $-15,431 | $-12,300 | $-8,615 |
| Total Liabilities And Equity | $236 | $196 | $1,678 | $1,480 | $1,939 |